ClinicalTrials.Veeva

Menu

Facemasks and Chronic Pain Patients With Hearing Loss

S

Salem Anaesthesia Pain Clinic

Status

Completed

Conditions

Chronic Pain
Hearing Loss

Treatments

Behavioral: Verbal communication

Study type

Observational

Funder types

Other

Identifiers

NCT06072235
Salem2018 HearLoss Pain Mask

Details and patient eligibility

About

Facemasks may impede communication. Impaired communication may worsen healthcare outcomes. This study explores the problem of hearing impairment in chronic pain patients, and the impact of facemasks on healthcare outcomes in chronic pain patients.

Data collection includes patient's age, anxiety score, depression score, numeric pain score, and effects of facemasks on treatment outcomes. Pain is measured using numeric pain rating scale. Depression is measured using the Patient Health Questionnaire (PHQ-9) scale. Anxiety is measured using the General Anxiety Disorder (GAD-7) scale.

Full description

Facemasks may impede communication. Impaired communication may worsen healthcare outcomes. There is inadequate data on the prevalence of hearing impairment in chronic pain patients. There is inadequate information about the impact of facemasks on treatment outcomes in chronic pain patients with hearing impairment. This prospective study explores the problem of hearing impairment in chronic pain patients, and the impact of facemasks on healthcare outcomes in chronic pain patients.

This is a prospective cohort study of adult patients undergoing pain treatment at an interventional pain clinic in Canada. Data collection includes patient's age, anxiety score, depression score, analgesic usage, numeric pain score, and effects of facemasks on pain management outcomes. Pain is measured using numeric pain rating scale of 0-10, with change of 2-points being considered significant. Depression is measured using the Patient Health Questionnaire (PHQ-9) scale of 0-27, with change of 3-points being considered significant. Anxiety is measured using the General Anxiety Disorder (GAD-7) scale of 0-21, with change of 3-points being considered significant.

Data are analyzed with IBM® SPSS® Statistics 25; using Student's t-test, ANOVA, Pearson Chi-square test, and regression analysis. P-value <0.05 is considered significant.

Enrollment

500 patients

Sex

All

Ages

20 to 99 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • adults
  • chronic pain diagnosis
  • diagnosed hearing impairment
  • use of hearing aid

Exclusion criteria

  • complete deafness
  • cochlear implant
  • severe vision impairment
  • cognitive dysfunction

Trial contacts and locations

1

Loading...

Central trial contact

Olu Bamgbade, MD,FRCPC; Olumuyiwa Bamgbade, MD,FRCPC

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems